Value-Based Care

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

With a $60M Series A, Chamber Cardio is using AI and risk-sharing to move cardiology to a value-based model, aiming to fix America's costliest disease.

Wolters Kluwer's UpToDate again tops KLAS rankings, highlighting a major trend: integrating expert-backed patient education directly into clinical care.

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

CoSara Diagnostics' ISO 13485 certification paves the way for regulatory approval of a new PCR platform, leveraging India's 'Make in India' initiative.

With multiple Best in KLAS awards, Bluesight cements its leadership in patient safety and data security. Here's why hospitals trust their solutions.

Celebrating 100 quarters of growth and a new HQ, MDVIP's success highlights a major shift toward personalized, prevention-focused healthcare models.

With a top industry award, CodaMetrix validates autonomous AI's power to fix healthcare's costly billing woes, reshaping both finances and jobs.

MetaVia's drug vanoglipel gets a major boost from AI modeling, validating its potential to treat complex metabolic diseases like MASH and Type 2 Diabetes.

A top KLAS award reveals a new era in healthcare cybersecurity, where measurable risk reduction and financial value are becoming more important than ever.

An expanded partnership aims to deliver a once-daily oral tablet for hypoparathyroidism, potentially revolutionizing treatment for thousands of patients.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

With crucial data on its novel oral inflammation inhibitor looming, NodThera brings in seasoned leader Geoff McDonough to navigate the path to Phase 3.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

Superior Health's acquisition of Pulse Home Health, backed by private equity, signals a major shift in Louisiana's booming home health and hospice market.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

Landmark legislation targets pharmacy benefit managers to end restrictive practices, promising better access for patients with complex diseases.

As the FDA embraces advanced Bayesian statistics, MedTech firm BioStem sees validation for its wound care research, promising faster innovation for patients.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.